EMA Withdrawn: Enzepi (pancreas powder) — Allergan Pharmaceuticals International Limited

View source ↗

Summary

The EMA has withdrawn Enzepi (pancreas powder) for exocrine pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Enzepi (pancreas powder)

Snippet

Status: Withdrawn. Therapeutic area: Exocrine Pancreatic Insufficiency. MAH: Allergan Pharmaceuticals International Limited. Decision date: 02/09/2016